Zydus Pharmaceuticals Inc, USA, a fully-owned subsidiary of Cadila Healthcare (Zydus Cadila), has signed a license and supply deal with CHEMI SpA for launching the generic version of Sanofi Aventis’s Lovenox (Enoxaparin Sodium Injection) in the US. The generic equivalent of Enoxaparin Sodium Injection has been launched in seven dosage strengths. Enoxaparin Sodium Injection is […]
Cadila Healthcare (also known as Zydus Cadila) said that it has adopted a new technology initiative called ‘Zydus Verify’ to protect patients against counterfeit drugs. In this connection, the Indian pharma company has rolled out a new feature in the packaging of its critical drugs for helping patients in identifying whether the product is genuine […]
Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma company TLC to commercialize the latter’s Black Fungus drug – AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. As per the terms of the deal, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to […]
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment of moderate Covid-19 infection in adult patients. According to the Indian pharma company, a single dose subcutaneous regimen of Virafin will make the treatment more easier for the patients. When […]